Free Trial

EssilorLuxottica (OTCMKTS:ESLOY) Sees Large Volume Increase - Should You Buy?

EssilorLuxottica logo with Medical background

Key Points

  • EssilorLuxottica experienced a significant increase in trading volume, with approximately 75,136 shares traded, marking an 82% rise from the previous session.
  • Equities analysts have reacted to the stock, with Barclays starting coverage with an "overweight" rating and Zacks upgrading it from "strong sell" to "hold," resulting in an average rating of "Hold" from analysts.
  • The company has a current ratio of 0.95 and a debt-to-equity ratio of 0.17, indicating reasonable liquidity and low leverage relative to equity.
  • Five stocks we like better than EssilorLuxottica.

Shares of EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY - Get Free Report) saw unusually-strong trading volume on Friday . Approximately 75,136 shares changed hands during trading, an increase of 82% from the previous session's volume of 41,233 shares.The stock last traded at $154.68 and had previously closed at $156.30.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on ESLOY shares. Zacks Research raised shares of EssilorLuxottica from a "strong sell" rating to a "hold" rating in a research report on Wednesday, September 10th. Barclays started coverage on shares of EssilorLuxottica in a research report on Tuesday, September 9th. They set an "overweight" rating on the stock. One equities research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold".

Check Out Our Latest Stock Analysis on ESLOY

EssilorLuxottica Trading Down 0.5%

The company's 50-day simple moving average is $150.49 and its 200 day simple moving average is $144.93. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.65 and a current ratio of 0.95.

EssilorLuxottica Company Profile

(Get Free Report)

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands.

Read More

Should You Invest $1,000 in EssilorLuxottica Right Now?

Before you consider EssilorLuxottica, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EssilorLuxottica wasn't on the list.

While EssilorLuxottica currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.